Variant report
Variant | esv1850560 |
---|---|
Chromosome Location | chr3:99920884-99924774 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252759 | chromatin interactions |
ENSG00000013441 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11719857 | chr3:99920884-99920885 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs186586658 | chr3:99920888-99920889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11707768 | chr3:99920920-99920921 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs191887485 | chr3:99920928-99920929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374995081 | chr3:99920933-99920934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140174559 | chr3:99920934-99920935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574735478 | chr3:99920941-99920942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181178423 | chr3:99921050-99921051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569144836 | chr3:99921070-99921071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142937838 | chr3:99921097-99921098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs74642383 | chr3:99921099-99921100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs151088750 | chr3:99921162-99921163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534139370 | chr3:99921291-99921292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111896294 | chr3:99921294-99921295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574280042 | chr3:99921319-99921320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566225338 | chr3:99921336-99921337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149800487 | chr3:99921344-99921345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556958557 | chr3:99921568-99921569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533342779 | chr3:99921576-99921577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116342822 | chr3:99921601-99921602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2178397 | chr3:99921609-99921610 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs545946029 | chr3:99921690-99921691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554663137 | chr3:99921695-99921696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145735530 | chr3:99921760-99921761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140530834 | chr3:99921763-99921764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145619182 | chr3:99921765-99921766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371119119 | chr3:99921776-99921777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529224458 | chr3:99921803-99921804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550594403 | chr3:99921804-99921805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199855448 | chr3:99921810-99921811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186623620 | chr3:99921812-99921813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2029163 | chr3:99921816-99921817 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs559058095 | chr3:99921861-99921862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566432092 | chr3:99921870-99921871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112600995 | chr3:99921871-99921872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533984750 | chr3:99921878-99921879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12696064 | chr3:99921885-99921886 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs375206399 | chr3:99921898-99921899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191325571 | chr3:99921899-99921900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560432542 | chr3:99921910-99921911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527582121 | chr3:99921935-99921936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182124350 | chr3:99921957-99921958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113465458 | chr3:99921972-99921973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112240960 | chr3:99921999-99922000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572982180 | chr3:99922002-99922003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185251047 | chr3:99922011-99922012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79498303 | chr3:99922052-99922053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561962823 | chr3:99922073-99922074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs117590547 | chr3:99922107-99922108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376965776 | chr3:99922120-99922121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16608533 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:99917600-99928600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr3:99917800-99933000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr3:99920600-99922800 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr3:99922800-99923000 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
5 | chr3:99923000-99928000 | Weak transcription | H9 Cell Line | embryonic stem cell |
6 | chr3:99924000-99924400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr3:99924200-99924800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr3:99924400-99928800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |